Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.04B |
| 2 |
Chevron
CVX
|
+$820M |
| 3 |
Shopify
SHOP
|
+$599M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$539M |
| 5 |
Meta Platforms (Facebook)
META
|
+$479M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$675M |
| 2 |
Tesla
TSLA
|
+$661M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$633M |
| 4 |
Verizon
VZ
|
+$533M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$377M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.47% |
| 2 | Technology | 16.84% |
| 3 | Consumer Staples | 11.12% |
| 4 | Consumer Discretionary | 10.18% |
| 5 | Financials | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2451
Denison Mines
DNN
$2.96B
| $1.43M | ﹤0.01% |
1,470,420
+468,707
| +47% | +$601K |
|
|
TECX
2452
Tectonic Therapeutic
TECX
$670M
| $1.43M | ﹤0.01% |
129,650
+55,892
| +76% | +$659K |
|
2453
PDS Biotechnology
PDSB
$13.3M
| $1.43M | ﹤0.01% |
391,037
-274,000
| -41% | -$1.3M |
|
|
ARGO
2454
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $1.43M | ﹤0.01% |
38,665
-22,806
| -37% | -$937K |
|
2455
iShares TIPS Bond ETF
TIP
$14.7B
| $1.42M | ﹤0.01% |
+12,500
| New | +$1.48M |
|
|
SEV
2456
DELISTED
Sono Group N.V. Common Shares
SEV
| $1.42M | ﹤0.01% |
484,200
+394,400
| +439% | +$1.53M |
|
2457
VTEX
VTEX
$623M
| $1.42M | ﹤0.01% |
461,900
+233,300
| +102% | +$1.13M |
|
2458
Invesco S&P 500 Equal Weight Energy ETF
RSPG
$606M
| $1.42M | ﹤0.01% |
+23,100
| New | +$1.62M |
|
2459
Gyre Therapeutics
GYRE
$689M
| $1.42M | ﹤0.01% |
106,265
-49,717
| -32% | -$330K |
|
2460
Limbach Holdings
LMB
$539M
| $1.42M | ﹤0.01% |
265,571
-7,600
| -3% | -$46.7K |
|
|
PETQ
2461
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $1.42M | ﹤0.01% |
84,300
+47,200
| +127% | +$866K |
|
|
MLVF
2462
DELISTED
Malvern Bancorp, Inc.
MLVF
| $1.42M | ﹤0.01% |
88,064
-8,900
| -9% | -$142K |
|
|
NOAH
2463
Noah Holdings
NOAH
$590M
| $1.41M | ﹤0.01% |
69,900
+59,500
| +572% | +$1.11M |
|
|
MAGN
2464
Magnera Corp
MAGN
$430M
| $1.41M | ﹤0.01% |
15,808
-3,115
| -16% | -$373K |
|
2465
Ocugen
OCGN
$451M
| $1.41M | ﹤0.01% |
+621,856
| New | +$1.49M |
|
|
LFG
2466
DELISTED
Archaea Energy Inc.
LFG
| $1.41M | ﹤0.01% |
90,900
-33,800
| -27% | -$686K |
|
2467
TTEC Holdings
TTEC
$80.8M
| $1.41M | ﹤0.01% |
+20,722
| New | +$1.45M |
|
2468
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.75B
| $1.4M | ﹤0.01% |
+29,200
| New | +$1.47M |
|
2469
Chicago Rivet & Machine Co
CVR
$9.98M
| $1.4M | ﹤0.01% |
49,210
+500
| +1% | +$13.5K |
|
2470
Kodiak Sciences
KOD
$2.54B
| $1.4M | ﹤0.01% |
+183,500
| New | +$1.29M |
|
|
RDUS
2471
DELISTED
Radius Recycling
RDUS
| $1.4M | ﹤0.01% |
+42,696
| New | +$1.82M |
|
|
SAGE
2472
DELISTED
Sage Therapeutics
SAGE
| $1.4M | ﹤0.01% |
+43,400
| New | +$1.45M |
|
|
RXDX
2473
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $1.4M | ﹤0.01% |
+49,600
| New | +$1.44M |
|
|
ITI
2474
DELISTED
Iteris, Inc.
ITI
| $1.4M | ﹤0.01% |
483,285
-104,600
| -18% | -$291K |
|
|
DALN
2475
DELISTED
DallasNews
DALN
| $1.39M | ﹤0.01% |
220,151
-21,550
| -9% | -$143K |
|
Similar funds
Jim Simons's Q2 2022 Portfolio in Review
As of Q2 2022, Jim Simons held 4,738 positions worth $84.5B, down 0.87% from $85.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $13.7B of net new capital in Q2 2022, opening 694 new positions and adding to 1,955 existing holdings. Its largest new stake was Microsoft: 3,820,133 shares worth $981M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Staples.
On the sell side, the largest reduction was Tesla, an estimated $661M trimmed.
- Jim Simons's largest Q2 2022 buy was Microsoft: 3,820,133 shares worth $981M.
- Jim Simons added most to Chevron in Q2 2022, an estimated $820M increase.
- Jim Simons's biggest Q2 2022 reduction was Tesla, cutting an estimated $661M.
- Jim Simons fully exited Amazon in Q2 2022, selling an estimated $675M.
- Jim Simons's ten largest holdings make up 11% of its $84.5B portfolio in Q2 2022.
- Jim Simons opened 694 new positions and closed 562 in Q2 2022.
- Jim Simons's portfolio value fell 0.87% quarter-over-quarter to $84.5B.
Based on Renaissance Technologies's 13F filing for Q2 2022, filed 12 Aug 2022.